Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
35,869,477
-
Shares change
-
-166,580
-
Total reported value, excl. options
-
$1,129,692,915
-
Value change
-
-$1,485,647
-
Put/Call ratio
-
27%
-
Number of buys
-
115
-
Number of sells
-
100
-
Price
-
$31.53
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2016
As of 30 Sep 2016 Emergent BioSolutions Inc. - Common Stock (EBS) had 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 35,869,477 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, GLENMEDE TRUST CO NA, RENAISSANCE TECHNOLOGIES LLC, ABERDEEN ASSET MANAGEMENT PLC/UK, GOLDMAN SACHS GROUP INC, and BlackRock Institutional Trust Company, N.A..
This table shows 252 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.